FACULTY AWARD: Ploss receives early-career award for infectious-disease research

By Staff on July 8, 2016, 10 a.m.

Alexander Ploss, a Princeton University assistant professor of molecular biology, has received an Investigators in Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund. Ploss will use the five-year, $500,000 award for his topic, "breaking species barriers of human hepatotropic pathogens." Based in Raleigh, North Carolina, the private Burroughs Wellcome Fund aims to advance the biomedical sciences by supporting research in pathogenesis, particularly by early-career scientists in lesser-known or fledgling biomedical fields, that focuses on the interplay between human and microbial biology.

Related Stories

FACULTY AWARD: Korennykh receives early-career award for infectious-disease research .

Alexei Korennykh, a Princeton University assistant professor of molecular biology, was selected for a 2014 Investigators in Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund. The award provides $500,000 over five years.  

Four faculty selected as Howard Hughes investigators .

Four Princeton faculty members are among 56 researchers who have been selected as the newest class of Howard Hughes Medical Institute investigators. Being selected is one of the highest honors in biomedical research.

More possible entry points for COVID spike protein identified by Princeton scientists .

Princeton scientists have revealed some of the unknown ways that COVID infects the human lung, using a new technology that shines a light (literally) on the actions of spike proteins.

Princeton researchers find a path toward Hep E treatment by disentangling its knotty structure .

The hepatitis E virus protein ORF1 contains a region that scientists have struggled to characterize, making the structure and function of this region the subject of much debate. Now, Princeton scientists show that this region of the protein does not behave as a protease, as has been previously suggested, but instead serves as a molecular scaffold to stabilize the rest of the ORF1 protein.

Princeton researchers listen in on the chemical conversation of the human microbiome .

Princeton researchers have developed new computational and experimental tools to identify microbial small molecules encoded in clinical samples, allowing scientists to explore microbial-host interactions and to mine the human microbiome for drug discovery.

Viral escape hatch could be treatment target for hepatitis E .

Researchers at Princeton and Rutgers universities have found that the hepatitis E virus — an emerging liver virus historically found in developing countries but now on the rise in Europe — uses a technique to spread infection that scientists could in fact exploit to treat the disease.

Princeton faculty win prestigious NIH awards .

Four Princeton faculty members have been awarded grants from the National Institutes of Health for work deemed "high impact" by the federal medical research agency.